title: Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine.
authors.forename: J A
authors.initials: JA
authors.lastname: Pineda
authors.forename: J
authors.initials: J
authors.lastname: Larrauri
authors.forename: J
authors.initials: J
authors.lastname: Macías
authors.forename: A
authors.initials: A
authors.lastname: Hernández
authors.forename: J
authors.initials: J
authors.lastname: Guijarro
authors.forename: M
authors.initials: M
authors.lastname: Sayago
authors.forename: F
authors.initials: F
authors.lastname: Gavilán
authors.forename: J
authors.initials: J
authors.lastname: Aguilar
authors.forename: E
authors.initials: E
authors.lastname: Lissen
mesh_terms: D000328:Adult; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001557:Benzenesulfonates / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications*; D018450:Disease Progression; D005260:Female; D006635:Histamine H2 Antagonists / Q000009:adverse effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D013844:Thiazoles / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D000897:Anti-Ulcer Agents; D001557:Benzenesulfonates; D006635:Histamine H2 Antagonists; D013844:Thiazoles; C075156:ebrotidine